spacer
spacer

PDBsum entry 6haw

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Electron transport PDB id
6haw

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
438 a.a.
413 a.a.
378 a.a.
239 a.a.
196 a.a.
99 a.a.
74 a.a.
64 a.a.
46 a.a.
59 a.a.
Ligands
6PE
PGE ×4
PO4 ×11
CDL ×4
PG4
PX6 ×2
HEM ×2
LMT
PEE ×2
FX2
HEC
FES
PX4
Waters ×30
PDB id:
6haw
Name: Electron transport
Title: Crystal structure of bovine cytochrome bc1 in complex with 2-pyrazolyl quinolone inhibitor wdh2g7
Structure: Cytochrome b-c1 complex subunit 1, mitochondrial. Chain: a. Synonym: complex iii subunit 1,core protein i,ubiquinol-cytochromE-C reductase complex core protein 1. Cytochrome b-c1 complex subunit 2, mitochondrial. Chain: b. Cytochrome b. Chain: c. Synonym: complex iii subunit 3,complex iii subunit iii,cytochrome b-
Source: Bos taurus. Cattle. Organism_taxid: 9913. Organism_taxid: 9913
Resolution:
3.45Å     R-factor:   0.212     R-free:   0.242
Authors: K.Amporndanai,W.D.Hong,P.M.O'Neill,S.S.Hasnain,S.V.Antonyuk
Key ref: W.David Hong et al. (2018). Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties. ACS Med Chem Lett, 9, 1205-1210. PubMed id: 30613327 DOI: 10.1021/acsmedchemlett.8b00371
Date:
08-Aug-18     Release date:   16-Jan-19    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P31800  (QCR1_BOVIN) -  Cytochrome b-c1 complex subunit 1, mitochondrial from Bos taurus
Seq:
Struc:
480 a.a.
438 a.a.
Protein chain
Pfam   ArchSchema ?
P23004  (QCR2_BOVIN) -  Cytochrome b-c1 complex subunit 2, mitochondrial from Bos taurus
Seq:
Struc:
453 a.a.
413 a.a.
Protein chain
Pfam   ArchSchema ?
P00157  (CYB_BOVIN) -  Cytochrome b from Bos taurus
Seq:
Struc:
379 a.a.
378 a.a.
Protein chain
Pfam   ArchSchema ?
P00125  (CY1_BOVIN) -  Cytochrome c1, heme protein, mitochondrial from Bos taurus
Seq:
Struc:
325 a.a.
239 a.a.
Protein chain
Pfam   ArchSchema ?
P13272  (UCRI_BOVIN) -  Cytochrome b-c1 complex subunit Rieske, mitochondrial from Bos taurus
Seq:
Struc:
274 a.a.
196 a.a.
Protein chain
Pfam   ArchSchema ?
P00129  (QCR7_BOVIN) -  Cytochrome b-c1 complex subunit 7 from Bos taurus
Seq:
Struc:
111 a.a.
99 a.a.*
Protein chain
Pfam   ArchSchema ?
P13271  (QCR8_BOVIN) -  Cytochrome b-c1 complex subunit 8 from Bos taurus
Seq:
Struc:
82 a.a.
74 a.a.
Protein chain
Pfam   ArchSchema ?
P00126  (QCR6_BOVIN) -  Cytochrome b-c1 complex subunit 6, mitochondrial from Bos taurus
Seq:
Struc:
91 a.a.
64 a.a.
Protein chain
Pfam   ArchSchema ?
P13272  (UCRI_BOVIN) -  Cytochrome b-c1 complex subunit Rieske, mitochondrial from Bos taurus
Seq:
Struc:
274 a.a.
46 a.a.
Protein chain
Pfam   ArchSchema ?
P00130  (QCR9_BOVIN) -  Cytochrome b-c1 complex subunit 9 from Bos taurus
Seq:
Struc:
64 a.a.
59 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 2: Chains A, B, C, F, G, H, J: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 3: Chains D, E, I: E.C.7.1.1.8  - quinol--cytochrome-c reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a quinol + 2 Fe(III)-[cytochrome c](out) = a quinone + 2 Fe(II)- [cytochrome c](out) + 2 H(+)(out)
quinol
+ 2 × Fe(III)-[cytochrome c](out)
= quinone
+ 2 × Fe(II)- [cytochrome c](out)
+ 2 × H(+)(out)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Key reference    
 
 
DOI no: 10.1021/acsmedchemlett.8b00371 ACS Med Chem Lett 9:1205-1210 (2018)
PubMed id: 30613327  
 
 
Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties.
W.David Hong, S.C.Leung, K.Amporndanai, J.Davies, R.S.Priestley, G.L.Nixon, N.G.Berry, S.Samar Hasnain, S.Antonyuk, S.A.Ward, G.A.Biagini, P.M.O'Neill.
 
  ABSTRACT  
 
A series of 2-pyrazolyl quinolones has been designed and synthesized in 5-7 steps to optimize for both in vitro antimalarial potency and various in vitro drug metabolism and pharmacokinetics (DMPK) features. The most potent compounds display no cross-resistance with multidrug resistant parasite strains (W2) compared to drug sensitive strains (3D7), with IC50 (concentration of drug required to achieve half maximal growth suppression) values in the range of 15-33 nM. Furthermore, members of the series retain moderate activity against the atovaquone-resistant parasite isolate (TM90C2B). The described 2-pyrazoyl series displays improved DMPK properties, including improved aqueous solubility compared to previously reported quinolone series and acceptable safety margin through in vitro cytotoxicity assessment. The 2-pyrazolyl quinolones are believed to bind to the ubiquinone-reducing Qi site of the parasite bc1 complex, which is supported by crystallographic studies of bovine cytochrome bc1 complex.
 

 

spacer

spacer